Scott, I. U., VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., & Blodi, B. A. (2022). Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion. American journal of ophthalmology, 240, 330-341. https://doi.org/10.1016/j.ajo.2022.04.001
Chicago-Zitierstil (17. Ausg.)Scott, Ingrid U., Paul C. VanVeldhuisen, Neal L. Oden, Michael S. Ip, und Barbara A. Blodi. "Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion." American Journal of Ophthalmology 240 (2022): 330-341. https://doi.org/10.1016/j.ajo.2022.04.001.
MLA-Zitierstil (9. Ausg.)Scott, Ingrid U., et al. "Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion." American Journal of Ophthalmology, vol. 240, 2022, pp. 330-341, https://doi.org/10.1016/j.ajo.2022.04.001.